1. Home
  2. VCYT vs BKD Comparison

VCYT vs BKD Comparison

Compare VCYT & BKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VCYT
  • BKD
  • Stock Information
  • Founded
  • VCYT 2006
  • BKD 2005
  • Country
  • VCYT United States
  • BKD United States
  • Employees
  • VCYT N/A
  • BKD N/A
  • Industry
  • VCYT Medical Specialities
  • BKD Hospital/Nursing Management
  • Sector
  • VCYT Health Care
  • BKD Health Care
  • Exchange
  • VCYT Nasdaq
  • BKD Nasdaq
  • Market Cap
  • VCYT 2.9B
  • BKD 2.5B
  • IPO Year
  • VCYT 2013
  • BKD 2005
  • Fundamental
  • Price
  • VCYT $48.53
  • BKD $11.22
  • Analyst Decision
  • VCYT Buy
  • BKD Buy
  • Analyst Count
  • VCYT 9
  • BKD 4
  • Target Price
  • VCYT $43.56
  • BKD $11.13
  • AVG Volume (30 Days)
  • VCYT 1.2M
  • BKD 4.4M
  • Earning Date
  • VCYT 11-04-2025
  • BKD 11-06-2025
  • Dividend Yield
  • VCYT N/A
  • BKD N/A
  • EPS Growth
  • VCYT N/A
  • BKD N/A
  • EPS
  • VCYT 0.38
  • BKD N/A
  • Revenue
  • VCYT $495,141,000.00
  • BKD $3,083,131,000.00
  • Revenue This Year
  • VCYT $14.52
  • BKD $8.53
  • Revenue Next Year
  • VCYT $9.90
  • BKD N/A
  • P/E Ratio
  • VCYT $125.41
  • BKD N/A
  • Revenue Growth
  • VCYT 16.41
  • BKD 4.35
  • 52 Week Low
  • VCYT $22.61
  • BKD $4.45
  • 52 Week High
  • VCYT $50.71
  • BKD $11.38
  • Technical
  • Relative Strength Index (RSI)
  • VCYT 71.15
  • BKD 80.60
  • Support Level
  • VCYT $37.98
  • BKD $10.43
  • Resistance Level
  • VCYT $50.71
  • BKD $11.38
  • Average True Range (ATR)
  • VCYT 2.11
  • BKD 0.48
  • MACD
  • VCYT 0.73
  • BKD 0.08
  • Stochastic Oscillator
  • VCYT 82.09
  • BKD 94.94

About VCYT Veracyte Inc.

Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.

About BKD Brookdale Senior Living Inc.

Brookdale Senior Living Inc operates senior living communities throughout the United States. The company has three reportable segments: Independent Living, Assisted Living and Memory Care, and Continuing Care Retirement Communities (CCRs). The majority of the revenue is generated from the Assisted Living and Memory Care segment, which offers housing and assistance with activities of daily living to its customers. The company generates revenue in the form of Resident Fees, which it receives in exchange for the services provided, and in the form of management fees from certain communities under contract in exchange for the management services provided.

Share on Social Networks: